Literature DB >> 6508097

The use of topical Healon tears in the management of refractory dry-eye syndrome.

V P DeLuise, W S Peterson.   

Abstract

We evaluated 28 patients with dry-eye syndrome in the setting of either primary or secondary Sjogren's syndrome, with topical Healon tears. In 26 of the 28 patients, we noted both subjective and objective improvement characterized by decreased itching, burning and foreign body sensation, decreased mucus stranding and Rose-Bengal staining of the cornea and conjunctiva, and increased corneal luster and tear break-up time.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6508097

Source DB:  PubMed          Journal:  Ann Ophthalmol        ISSN: 0003-4886


  15 in total

1.  Cytoprotective effect of hyaluronic acid and hydroxypropyl methylcellulose against DNA damage induced by thimerosal in Chang conjunctival cells.

Authors:  Juan Ye; Huina Zhang; Han Wu; Changjun Wang; Xin Shi; Jiajun Xie; Jinjing He; Jun Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-06-24       Impact factor: 3.117

2.  Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye.

Authors:  Pasquale Aragona; Vincenzo Papa; Antonio Micali; Marcello Santocono; Giovanni Milazzo
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

Review 3.  Therapeutic dilemmas in external ocular diseases.

Authors:  P A Asbell; M A Torres
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

4.  Double blind, randomised, placebo controlled, crossover, multicentre study to determine the efficacy of a 0.1% (w/v) sodium hyaluronate solution (Fermavisc) in the treatment of dry eye syndrome.

Authors:  P I Condon; C G McEwen; M Wright; G Mackintosh; R J Prescott; C McDonald
Journal:  Br J Ophthalmol       Date:  1999-10       Impact factor: 4.638

5.  Effect of sodium hyaluronate (0.1%) on break-up time (NIBUT) in patients with dry eyes.

Authors:  L S Mengher; K S Pandher; A J Bron; C C Davey
Journal:  Br J Ophthalmol       Date:  1986-06       Impact factor: 4.638

6.  Clinical evaluation of the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye syndrome: a prospective, randomized, multicenter study.

Authors:  K Kamiya; M Nakanishi; R Ishii; H Kobashi; A Igarashi; N Sato; K Shimizu
Journal:  Eye (Lond)       Date:  2012-08-10       Impact factor: 3.775

7.  Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro.

Authors:  J A P Gomes; R Amankwah; A Powell-Richards; H S Dua
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

8.  Sodium hyaluronate eyedrops in the treatment of dry eyes.

Authors:  S Shimmura; M Ono; K Shinozaki; I Toda; E Takamura; Y Mashima; K Tsubota
Journal:  Br J Ophthalmol       Date:  1995-11       Impact factor: 4.638

Review 9.  Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing.

Authors:  K L Goa; P Benfield
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

10.  Assessment of dry eye signs and symptoms and ocular tolerance of a preservative-free lacrimal substitute (Hylabak®) versus a preserved lacrimal substitute (Systane®) used for 3 months in patients after LASIK.

Authors:  Yuri S Astakhov; Sergei Y Astakhov; Alla B Lisochkina
Journal:  Clin Ophthalmol       Date:  2013-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.